Could J147 help stroke patients recover better?
Disease control
Not yet recruiting
This phase 2 trial tests whether the drug J147, given by IV after clot removal, helps people recover from an acute ischemic stroke. About 196 participants will receive either J147 or a placebo. Researchers will measure brain function and safety through MRI scans and blood tests o…
Phase: PHASE2 • Sponsor: Abrexa Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC